CLYM · Climb Bio, Inc.
$12.41
+0.30 (+2.48%)
At close · Jul 30
Market Cap
$693.42M
Shares
57.26M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-06-30 | AOIFE BRENNAN | Officer, Director | 30,902 | 2026-06-29 | E-TRADE FINANCIAL CORPORATION |
| 2026-02-25 | STEPHEN THOMAS | Director | 50,000 | 2026-02-25 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-12 | STEPHEN THOMAS | Director | 100,000 | 2026-02-12 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–3 of 3 filings
Key facts
CIK
1768446
CUSIP
28658R106
13F (30d)
10 filings
10 filers
Visit website
Investor relations